Cocaine-associated retiform purpura is a recently described entity characterized by striking hemorrhagic necrosis involving areas of skin associated with administration of cocaine. Levamisole, an adulterant in cocaine, has been suggested as the main culprit pathogenetically. Four cases of cocaine-associated retiform purpura were encountered in the dermatopathology practice of C. M. Magro. The light microscopic findings were correlated with immunohistochemical and immunofluorescence studies. All 4 cases showed a very striking thrombotic diathesis associated with intravascular macrophage accumulation. Necrotizing vasculitis was noted in 1 case. Striking intercellular adhesion molecule-1 (ICAM-1)/CD54 expression in vessel wall along with endothelial expression of caspase 3 and extensive vascular C5b-9 deposition was observed in all biopsies examined. Cocaine-induced retiform purpura is a C5b-9mediated microvascular injury associated with enhanced apoptosis and prominent vascular expression of ICAM-1, all of which have been shown in prior in vitro and in vivo murine models to be a direct effect of cocaine metabolic products. Antineutrophilic cytoplasmic antibody and antiphospholipid antibodies are likely the direct sequelae of the proapoptotic microenvironment. The inflammatory vasculitic lesion could reflect the downstream end point reflective of enhanced ICAM-1 expression and the development of antineutrophilic cytoplasmic antibody. Levamisole likely works synergistically with cocaine in the propagation of this syndromic complex.
INTRODUCTION
Cocaine-associated retiform purpura is a recently described entity characterized by very striking hemorrhagic necrosis involving areas of skin including the cheek and ears temporally associated with administration of cocaine. It was first reported in 2010. 1 The usual route of administration is in the context of intranasal and/or inhalational cocaine. At one point it was thought to be exclusively attributable to cocaine. However, there is now a growing body of literature, suggesting that levamisole, which is an adulterant in cocaine, may play a significant role in the pathogenesis of cocaine-associated retiform purpura. 2, 3 The exact mechanism by which cocaine with or without levamisole induces the distinctive cutaneous vascular changes has not been fully elucidated in the skin. It has been suggested more recently that levamisole is the main culprit for this distinctive vascular injury syndrome even though thrombotic complications related directly to cocaine use are well known. Although the term levamisole-associated vasculitis has been applied by some authors to describe this discrete syndromic complex, many of the examples of cocaine-associated retiform purpura in fact represent a pauci-inflammatory thrombotic microangiopathy without true necrotizing inflammatory vasculitic changes. [4] [5] [6] [7] [8] [9] [10] The purpose of this study was to present 4 cases of cocaine-associated retiform purpura and to explore the pathophysiology of the microvascular changes, linking it with the known effects of cocaine and levamisole on the microvasculature.
MATERIALS AND METHODS
The cases were encountered in the routine and consultative dermatopathology practice of one of the authors (C.M. M.). In each case, hematoxylin and eosin-stained material was examined. Immunofluorescence studies were conducted on 3 cases, whereby immunoreactant deposition was assessed for immunoglobulin IgG, IgM, IgA, C3, C3d, C4d, and C5b-9. The methodology has been previously described. 11 The expression of caspase 3, C3d, C5b-9, and intercellular adhesion molecule-1 (ICAM-1)/CD54 was also explored on paraffin-embedded tissue in all cases. The methodology for each of these antibodies will be described in detail.
Immunohistochemical staining was performed on 4-mm-thick, formalin-fixed, paraffin-embedded tissue sections by using the Bond 3 Autostainer (Leica Microsystems, Buffalo Grove, IL) and the Bond Polymer Refine detection system (Leica Microsystems). Intercellular adhesion molecule-1/ CD54 (G-5) (sc-8439; Santa Cruz Biotechnology, Santa Cruz, CA) was used at a dilution of 1:2000. Cleaved caspase 3 (#9661; Cell Signaling Technology, Boston, MA) was used at a dilution of 1:50. C5b-9 (clone aE11; Dako, Carpinteria, CA) was applied at a dilution of 1:250. Antigen retrieval for C5b-9 was performed using enzyme 1 from the Bond Enzyme Pretreatment Kit (Leica Microsystems). Immunostaining was performed according to a modified manufacturer's protocol and sections were counterstained with hematoxylin, dehydrated, and embedded in Cytoseal XYL (Thermo Scientific, Kalamazoo, MI).
RESULTS
Each case was associated with classic clinical features of cocaine-induced retiform purpura. In particular, in each case, there was a temporal association between the administration of cocaine and the development of retiform purpura. A detailed account will be given of all 4 cases, and the clinical presentation was summarized in Table 1 and histological findings were summarized in Table 2 .
Case History Case 1
A 44-year-old female with a history of polysubstance abuse presented to the emergency department (ED) with a 2-week history of a tender nonpruritic purpuric rash on the trunk and bilateral extremities. She noted 2 prior episodes of similar eruption that resolved spontaneously without treatment and left no residual scarring. The patient denied any medical illnesses, but her drug history was notable for active cocaine use and occasional nonsteroidal anti-inflammatory drugs. A review of system revealed 1-year history of joint pain involving bilateral ankles, wrists, fingers, and knees, but she was otherwise negative for systemic complaints. On physical examination, retiform purpuric patches and plaques were noted on the abdomen, flank, and bilateral upper and lower extremities. The plaques on her thighs had also developed central necrosis. Her head and neck and distal extremities were not involved. She was afebrile and her physical examination, including joint examination, was unremarkable.
A laboratory evaluation including complete blood count, basic metabolic panel, and serologies to evaluate for vasculitis and coagulopathy was notable for an anticardiolipin IgM level of 56 IgM phospholipid (MPL) (nl: 0-12 MPL), a perinuclear antineutrophilic cytoplasmic antibody (p-ANCA) level of 103 AU/mL (nl: 0-19 AU/mL), positive lupus anticoagulant, and a positive antinuclear antibody (ANA) (1:160, speckled).
Despite the extensive involvement of her skin rash, the patient was otherwise stable. A skin biopsy was performed in the ED, and the patient was discharged home with topical wound care and dermatology outpatient follow-up. Her skin rash subsequently resolved spontaneously. She no longer uses cocaine. In this regard, she is currently asymptomatic without any further episodes.
Case 2
A 53-year-old female presented to the ED with a chief complaint of a nonpainful purpuric rash for 3 days accompanied by nausea and vomiting of dark-colored fluid. The rash started on her legs and spread upward to involve the rest of her body. She also had nonpainful oral lesions. She had similar rashes in the past, once that started on her breasts and then spread to her legs, and another occasion the rash was strictly on her legs ( Fig. 1 ). She admitted to regularly snorting cocaine every Friday, and it was the day after her last use that the lesions appeared. She complained of dark-colored urine but normal urine output. Although she denied joint pain, she did have some pain with swelling associated with her prior episodes. Her review of systems was otherwise unremarkable.
On examination, she had purpuric plaques with sharp irregular borders and a necrotic central crust on all 4 extremities, buttocks, and ears. The purpuric areas were indurated without much tenderness. There was overlying bullae on the lower extremities, with several having ruptured and expressing serosanguinous drainage through thigh dressings. There was no abdominal tenderness.
The patient was admitted for further evaluation and given the degree of skin involvement and necrosis, she was sent to the burn unit. Her laboratory studies were significant for positive ANCAs with myeloperoxidase and proteinase 3 specificities along with an anticardiolipin IgM level of 54 MPL. Her hospital course was complicated by a hemoglobin drop to 5.8 g/dL requiring transfusion. She required several visits to the operating room for wound debridement and split thickness skin allografts throughout her body.
Case 3
A 37-year-old female presented to the ED with a striking purpuric skin rash. Physical examination revealed extensive palpable purpura involving the ears, soles, thighs, and arms. The patient was thrombocytopenic and leukopenic. Despite the dramatic appearance of her skin rash, she was relatively asymptomatic. She had a prior history of cocaine use that antedated her syndromic complex by approximately 
Case 4
A 47-year-old female had a history of depression and corrective nasal surgery for progressive nasal bridge collapse in recent years and intermittent joint pain and swelling, which involved both small and large joints, with negative rheumatoid serologies. The patient reported to have a remote history of cocaine abuse with last use being 15 years ago. One week before her presentation to our hospital, she developed abrupt onset left upper quadrant abdominal pain followed by fever and painful purpuric skin lesions on her breasts, hips, and thighs. She was referred to the ED of an outside hospital by her primary care physician and was hospitalized. While there, her skin lesions rapidly spread to involve extensive portions of her body and she felt profoundly weak. Her urine analysis showed a protein level of 150 mg/dL and 250 red blood cells per high power field with a normal creatinine. Her laboratory tests also revealed leukopenia, anemia, and a high serum C-reactive protein level. A chest x-ray showed a left lobe infiltrate. A skin biopsy performed of her purpuric lesions was interpreted as necrotizing leukocytoclastic vasculitis for which she was started on high-dose corticosteroids together with antibiotics and her strength improved. The patient was then transferred to our hospital for further care.
On admission, she was not overall ill-appearing considering her dramatic skin lesions, which were confluent hemorrhagic purpura with overlying nontense, nontender bullae involving both arms, shoulders, legs and thighs, bilateral cheeks, ears, and scattered spots on the abdomen, chest, and back. Laboratory tests further revealed a serum c-ANCA level of 103 AU/mL (nl: 0-19 AU/mL) and a p-ANCA level of 29 AU/mL. At this point, her outside skin biopsy was reviewed and a diagnosis of levamisole/cocaine-induced retiform purpura was rendered. Further investigation revealed recent cocaine abuse just before the onset of the skin rash. The patient remained on prednisone and her skin rash dramatically improved. However, because of extensive breakdown of skin over her calf, she was admitted to the burn unit and received alloskin grafts.
Light Microscopic Findings
All biopsies showed a very striking thrombotic diathesis involving capillaries, venules, and arterioles throughout the dermis and subcutaneous tissue (Fig. 2) . And, in all biopsies, there was an intravascular accumulation of macrophages intimately associated with the intraluminal thrombi ( Fig. 3 ). There was evidence of endothelial cell degenerative changes with endothelial cell detachment/sloughing. A variable modest mononuclear cell infiltrate was also noted. In addition to these aforesaid changes, in one of the cases, there was evidence of a true necrotizing vasculitis over and above the aforesaid thrombotic vascular changes. Specifically, there was conspicuous concentric mural fibrin deposition with an angiocentric inflammatory cell infiltrate comprising neutrophils and mononuclear cells with marked leukocytoclasia (Fig. 4 ).
Complement Studies on Paraffin-Embedded Tissue and Tissue Fixed in Physiologic Fixative
Immunofluorescent studies showed very extensive granular deposition of C3d and C5b-9 within the endothelium, vessel wall, and thrombus in 3 of 3 cases in which direct immunofluorescence (DIF) studies were carried out. The staining intensity was +3/3 (Fig. 5A ). Immunohistochemical studies showed extensive vascular deposits of C3d and C5b-9 corresponding both qualitatively and quantitatively with the pattern and extent of staining observed with immunofluorescence ( Figs. 5B, 6 ).
Immunohistochemical Assessment of ICAM-1/CD54
Intercellular adhesion molecule-1/CD54 plays an important role in inflammatory processes; it is constitutively expressed at low levels on endothelial cell and on some lymphocytes and monocytes, but its expression can be significantly increased in the presence of cytokines. 12 Recently, the function of ICAM-1 has also been implicated in vascular inflammation, from atherosclerosis to vasculitis. 13, 14 We therefore examined the expression of ICAM-1 by immunohistochemistry. In all cases, ICAM-1 showed extensive staining both qualitatively and quantitatively in the endothelium, vessel wall, and perivascular inflammatory cells in all biopsies (Fig. 7 ).
Immunohistochemical Assessment of Caspase 3
Caspase 3 (CPP-32; Apoptain, Yama, SCA-1) is a critical executioner of apoptosis because it is either partially or totally responsible for the proteolytic cleavage of many key proteins, such as the nuclear enzyme poly-ADP ribose polymerase. 15 Caspase 3 staining could be either cytoplasmic or nuclear in nature. There was cytoplasmic expression of caspase 3 within the endothelium of vessels in all biopsies examined. In addition, there was enhanced nuclear and cytoplasmic expression of caspase 3 in perivascular inflammatory cells in all biopsies (Fig. 8) . The staining was very focal, with most vessels and inflammatory cells devoid of staining.
Control Studies
Five control samples from normal appearing skin of reexcision specimens were examined. There was endothelial cell expression of ICAM-1 in all the control samples; however, the staining intensity in the endothelium was less than that observed in the study cases and significant staining of perivascular inflammatory cells was not observed (Fig. 9 ). 
Examination of normal control biopsies revealed no caspase 3 staining in the dermis.
Expression of ICAM-1 and C5b-9 was also examined in various vasculitic entities including 3 cases of Henoch Schonlein purpura, 4 cases of leukocytoclastic vasculitis, and 2 cases of urticarial vasculitis and in thrombogenic vasculopathy including 1 case of antiphospholipid syndrome. As expected, strong expression of ICAM-1 was seen in the endothelial cells in vasculitis, with variable expression of ICAM-1 in perivascular inflammatory cells. Interestingly, however, deposition of C5b-9 was not observed in these vasculitic entities. On the contrary, extensive vascular deposits of C5b-9 were noted in thrombogenic vasculopathy, whereas ICAM-1 staining in perivascular inflammatory cells was minimal in the case examined. Therefore, the combination of strong ICAM-1 staining in both endothelial and perivascular inflammatory cells and deposition of C5b-9 in vessels seems characteristic of cocaine-associated purpura.
DISCUSSION
We have presented 4 classic cases of cocaine-induced retiform purpura. Cocaine-associated retiform purpura was first described by Waller and associates in 2010. They reported 2 patients who developed agranulocytosis and purpuric eruptions in association with lupus anticoagulant positivity and/or c-or p-ANCA positivity in the setting of intranasal cocaine use. 1 They hypothesized that this syndromic complex could largely be explained on the basis of levamisole use because of the striking similitude of the clinical lesions and serologic findings with levamisole-associated purpura in children receiving this agent for nephrotic syndrome. 16 Complete clinical resolution of skin lesions occurred 2-3 weeks after stopping levamisole and serologies normalized within 2-14 months. Based on prior reported cases, the most common antiphospholipid antibody reported with this syndrome is anticardiolipin antibody, although it is not clear based on these previously published studies if other antiphospholipids such as those directed toward cytoplasmic membrane-based phospholipids were specifically assessed. The ANCA subtype can be quite variable in this disorder comprising antibodies with specificity to myeloperoxidase, proteinase 3, cathespin, and neutrophilic elastase.
The histopathology in our cases of cocaine-associated retiform purpura was varied, representing 2 ends of a morphologic spectrum. The most common was a pauci-inflammatory thrombotic diathesis accompanied by intravascular monocytes along with evidence of endothelial cell apoptosis. The latter was characterized by prominent nuclear and/or cytoplasmic staining of endothelium for caspase 3. The less common pattern was a necrotizing vasculitis. In this latter scenario, the aforesaid thrombotic changes were also noted, but in addition, several vessels exhibited concentric mural fibrin along with angiocentric mononuclear cell and neutrophilic infiltrates. In addition, in all biopsies, there was evidence of extensive activation of the complement cascade sequence with localization of the membranolytic attack complex within the cutaneous vasculature. Hence, it seems that the common morphologic theme in all the biopsies was one of a thrombogenic vasculopathy associated with endothelial cell apoptosis and evidence of complement activation with C5b-9 as a potential effector mechanism of microvascular injury.
How does one link cocaine and possibly the adulterant levamisole with the aforesaid changes? And, how can a necrotizing cell-rich inflammatory vasculitis eventuate with the known effects of levamisole and cocaine on the microvasculature? There are many studies published in the basic science literature that really outline potential and probable mechanisms by which the cutaneous changes likely develop accounting for these very distinctive cutaneous microvascular alterations.
One of the most critical studies was by Tanhehco et al 17 entitled "Acute Cocaine Exposure Upregulates Complement Expression in the Rabbit Heart." The study used isolated perfused parts from rabbits treated with cocaine hydrochloride. They demonstrated that the metabolic products of cocaine promote complement synthesis and also lead to the deposition of C5b-9. Interestingly, the administration of heparin attenuated the deposition of C5b-9 and was cardioprotective, albeit it did not reduce complement synthesis. The authors of the same study found that enhanced complement transcription was likely triggered by free radicals produced in the component of cocaine metabolized by the cytochrome P-450 system. The antioxidant N-(2-Mercaptopropionyl)glycine reduced complement messenger RNA expression. 17 There are other catastrophic thrombotic microangiopathy syndromes triggered by C5b-9 18 including Degos disease, 19 catastrophic antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. [20] [21] [22] [23] In all these potentially devastating microangiopathic conditions, eculizumab has emerged as the treatment of choice. Eculizumab blocks C5 and prevents the formation of the membranolytic attack complex. Enhanced C5b-9 deposition related to cocaine-free radicals could induce vascular thrombosis through mechanisms that underlie those implicated for the other aforesaid catastrophic thrombotic syndromes. One would question whether or not a drug such as eculizumab could be effective in cocaine-associated retiform purpura.
Other studies have shown that vascular C5b-9 deposition leads to endothelial cell apoptosis. In addition, C5b-9 directly enhances apoptosis. [24] [25] [26] [27] [28] [29] [30] The endothelial cell detachment will eventually expose type IV collagen and induce activation of the clotting pathway. We have shown in a separate study that eculizumab directly reduces the extent of apoptosis, hence indicative of the effect of C5b-9 as an independent determinant of apoptosis. A further mechanism of endothelial cell apoptosis is one related to activation of activated protein 1 [31] [32] [33] [34] and nuclear factor-kappa B through the release of tumor necrosis factor (TNF)-a by cocaine-free radicals. [35] [36] [37] [38] [39] Endothelial cell apoptosis is not only a critical factor in the induction of vascular thrombosis but may also explain the inflammatory vasculitic lesions and the distinct autoreactive serologic profiles that emerge in these patients. Apoptosis either through C5b-9 deposition or the direct effects of cocaine in promoting the release of TNF-a leads to epitope spreading with the induction of neoantigens. It is known that patients with cocaine-associated retiform purpura have a very distinctive autoreactive antibody profile, specifically in regard to antibodies to phospholipids [40] [41] [42] [43] and antibodies to neutrophilic cytoplasmic-based proteins. [44] [45] [46] [47] Both antiphospholipid antibodies and ANCAs are the classic proapoptotic antibodies that form in the setting of accelerated apoptosis which, of course, is an event that happens in the setting of cocaine use through the mechanisms outlined above. The development of ANCA is likely triggered by the localized production of TNF-a. Tumor necrosis factor-a accelerates neutrophil apoptosis leading to the displacement of neutrophil granules to the surface. The presentation to the surface of neoantigens leads to the secondary formation of antibodies to these neutrophil-derived cytoplasmic granules. 48 In the same vein, phospholipids exhibit a localization within the cytoplasmic membrane, whereby there are phospholipids in the outer aspect of the membrane and those located in the inner layer of the cytoplasmic membrane including phosphatidyl ethanolamine, phosphatidyl choline, and phosphatidyl serine. [40] [41] [42] [43] Hence, with apoptosis, those inner cytoplasmic membranebased phospholipids become displaced to the surface, creating a state of neoantigenicity with secondary antiphospholipid antibody formation. One of the patients in this series had anti-Ro antibodies. Anti-Ro antibody is also a proapoptotic antibody that is formed in the setting of enhanced apoptosis. Enhanced apoptosis leads to the displacement of nuclear Ro to the surface of the cell. In summation, then, the cocaine-free radicals activate complement and accelerate apoptosis, which contributes to intraluminal thrombosis, and the apoptosis induces secondary proapoptotic antibody formation through the phenomenon of epitope spreading.
It is now felt that levamisole is an important factor in the evolution of cocaine-associated retiform purpura. It has been known for quite some time that levamisole can induce a vasculopathic/vasculitic syndrome in patients taking this drug. It was first reported to cause vasculitis associated with a purpuric livedoid rash as early as 1978 in patients receiving the drug for the treatment of rheumatoid arthritis. 49 In addition, there are reports of a virtually identical rash including infarcted ears occurring in young children receiving levamisole for the treatment of nephrotic syndrome. 16, 50 Like cocaine-associated retiform purpura, these patients had ANCAs with elastase specificity and antiphospholipid antibodies. Hence, the clinical presentation was remarkably similar to what has been described with cocaine-associated retiform purpura. Indeed, levamisole is the major adulterant in street cocaine. However, an important critical difference between cocaine-associated retiform purpura and levamisole-induced vasculitis as reported in the 1970s and 1990s in the setting of rheumatoid arthritis and nephrotic syndrome, respectively, is the fact that the retiform purpura is temporally associated with the immediate exposure to cocaine, whereas the levamisole-induced vasculitis cases had a very long latent period of months to years. 51, 52 It is more likely that levamisole works synergistically with cocaine as opposed to levamisole exclusively inducing retiform purpura in light of the immediate temporal association between the administration of cocaine and the development of the retiform purpura. Alkaline phosphatase activity on endothelial cell surfaces is responsible for the conversion of adenosine nucleotides to adenosine, which is a potent vasodilator and anti-inflammatory agent. Levamisole inhibits surface alkaline phosphatase activity on endothelium, exaggerating the adverse effects of cocaine. In addition, both levamisole and cocaine upregulate ICAM-1 expression. We were able to demonstrate extensive ICAM-1 expression within the microvasculature of our cases. There was marked staining within the endothelium, vessel wall, and inflammatory cells. This likely accounts for the very distinctive finding of intraluminal macrophages at all phases in the evolution of cocaine-associated retiform purpura skin lesions. In later stage lesions, the upregulation of ICAM-1 along with the generation of ANCA likely contributes to the efflux of inflammatory cells, resulting in a true inflammatory vasculitis. Intercellular adhesion molecule-1 is expressed in low concentrations within the membranes of leukocytes and endothelial cells; on stimulation, leukocytes bind to endothelium through the ICAM-1-lymphocyte function-associated antigen-1 interaction, facilitating migration through the vessel wall and into the surrounding tissue. 13, 14 Hence, cocaine-associated retiform purpura represents an acute C5b-9-mediated thrombotic angiopathy syndrome associated with a state of enhanced endothelial cell apoptosis and secondary formation of proapoptotic antibodies. These direct effects of cocaine are further compounded by similar FIGURE 10 . Schematics of proposed mechanism in cocaine-associated thrombotic vasculopathy and vasculitis.
proapoptotic and inflammatory effects of levamisole. It is likely that the incipient lesion in cocaine-associated retiform purpura is a thrombotic one with intraluminal macrophage accumulation, extensive C5b-9 deposition and enhanced apoptosis without true necrotizing vasculitic changes. The later stage lesions could be truly vasculitic, reflecting the effects of ANCA and enhanced ICAM-1 expression on the promotion of leukocyte influx (Fig. 10) . Although the induction of ICAM-1 and deposition of C5b-9 may not represent specific changes seen in cocaine-associated retiform purpura, understanding the pathophysiologic basis of the disease will allow more effective therapies to be established including the potential of use of drugs such as eculizumab. Inhibition of C5b-9 formation through eculizumab administration has halted the acute thrombotic diathesis observed in other settings including acute catastrophic thrombotic syndromes such as antiphospholipid antibody syndrome, paroxysmal nocturnal hemoglobinuria, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome. The exact mechanism by which blocking the formation of the terminal complement cascade abrogates acute intravascular thrombosis is not entirely known.
